[Effect of ethinyl estradiol sulfonate/norethisterone acetate on HGH secretion in pubertal girls].
In 13 healthy tall girls the influence of the hormonal treatment with depotestrogen ethinylestradiolsulfonate and norethisterone acetate was investigated on basal and arginine stimulated HGH secretion. The investigations were performed before, during and after finishing the therapy. HGH serum levels were determined by RIA. During the hormonal therapy the mean basal HGH levels were significant higher (p less than 0.05) than before or after therapy. Independent from hormonal therapy there was no stimulation of the HGH secretion by arginine in about 2/3 of the girls.
D000293:Adolescent; D000328:Adult; D001120:Arginine; D001827:Body Height / Q000187:drug effects*; D006063:Chorionic Gonadotropin / Q000097:blood*; D004359:Drug Therapy, Combination; D004997:Ethinyl Estradiol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D009640:Norethindrone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000077563:Norethindrone Acetate; D010906:Pituitary Hormone-Releasing Hormones; D011627:Puberty / Q000187:drug effects*; D011863:Radioimmunoassay; D013973:Thyrotropin-Releasing Hormone
D006063:Chorionic Gonadotropin; D010906:Pituitary Hormone-Releasing Hormones; C025723:ethinyl estradiol sulfonate; D004997:Ethinyl Estradiol; D013973:Thyrotropin-Releasing Hormone; D001120:Arginine; D000077563:Norethindrone Acetate; D009640:Norethindrone
Einfluss von Athinylöstradiolsulfonat/Noräthisteronazetat auf die HGH-Sekretion bei puberalen Mädchen.